Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bioverativ
Bioverativ
Coming soon to the Nasdaq: Biogen's hemophilia spinoff
Bizjournals.com
Tue, 12/27/16 - 10:33 am
Biogen
NASDAQ
Bioverativ
spinoffs
hemophilia
Biogen Approves Spin-out of Hemophilia Business
TheStreet.com
Wed, 12/21/16 - 10:51 am
Biogen
spinoffs
hemophilia
Bioverativ
Sangamo to transfer two gene therapies to Biogen spin-off
BioPharma Dive
Thu, 12/1/16 - 04:24 pm
Sangamo
gene therapy
Biogen
Bioverativ
sickle cell disease
beta-thalassemia
Biogen's hemophilia business spinoff planned for early 2017
Marketwatch
Tue, 08/9/16 - 11:29 am
Biogen
spinoff
hemophilia
Bioverativ
Pages
« first
‹ previous
1
2